Czech National Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Czech National Bank's ABBV Position: Q2 2026 in Review
Czech National Bank increased its AbbVie (ABBV) stake by 4.5% in Q2 2026, buying an estimated $4.64M and bringing the position to 502,897 shares worth $127M. The position accounts for 0.69% of the portfolio, ranked #24.
Czech National Bank first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Czech National Bank held 502,897 shares of AbbVie worth $127M as of Q2 2026.
- Czech National Bank bought 21,557 AbbVie shares in Q2 2026, an estimated $4.64M.
- AbbVie made up 0.69% of Czech National Bank's portfolio in Q2 2026, its #24 holding.
- Czech National Bank first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
- 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.